CFC Use In OTC Epinephrine Inhalers Topic Of Upcoming NDAC Meeting
This article was originally published in The Tan Sheet
Executive Summary
FDA's Nonprescription Drugs and Pulmonary-Allergy Drugs advisory committees will discuss the availability of OTC epinephrine metered-dose inhalers (MDIs) and their environmental impact during a joint meeting scheduled for Jan. 24.